These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25641951)

  • 1. Systems biology of polycystic kidney disease: a critical review.
    Menezes LF; Germino GG
    Wiley Interdiscip Rev Syst Biol Med; 2015; 7(1):39-52. PubMed ID: 25641951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gretchen question in autosomal-dominant polycystic kidney disease research.
    Luft FC
    J Mol Med (Berl); 2011 Mar; 89(3):247-50. PubMed ID: 21301792
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
    Cai Y; Tang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polycystin-centric view of cyst formation and disease: the polycystins revisited.
    Ong AC; Harris PC
    Kidney Int; 2015 Oct; 88(4):699-710. PubMed ID: 26200945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARPKD and ADPKD: first cousins or more distant relatives?
    Kaimori JY; Germino GG
    J Am Soc Nephrol; 2008 Mar; 19(3):416-8. PubMed ID: 18272839
    [No Abstract]   [Full Text] [Related]  

  • 6. An ever-expanding story of cyst formation.
    Gallagher AR; Obermüller N; Cedzich A; Gretz N; Witzgall R
    Cell Tissue Res; 2000 Jun; 300(3):361-71. PubMed ID: 10928266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of polycystic kidney disease.
    Wilson PD
    Biochim Biophys Acta; 2011 Oct; 1812(10):1201. PubMed ID: 21884966
    [No Abstract]   [Full Text] [Related]  

  • 8. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease.
    Fragiadaki M; Lannoy M; Themanns M; Maurer B; Leonhard WN; Peters DJ; Moriggl R; Ong AC
    Kidney Int; 2017 Mar; 91(3):575-586. PubMed ID: 28104302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2.
    Ravichandran K; Ozkok A; Wang Q; Mullick AE; Edelstein CL
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F349-57. PubMed ID: 25537744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.
    Saigusa T; Bell PD
    Physiology (Bethesda); 2015 May; 30(3):195-207. PubMed ID: 25933820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
    Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
    Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in molecular genetics of autosomal dominant polycystic kidney disease.
    Trudel M; Guillaume R
    Front Biosci; 2000 Mar; 5():D312-20. PubMed ID: 10704432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathogenesis of autosomal dominant polycystic kidney disease.
    Yoder BK; Mulroy S; Eustace H; Boucher C; Sandford R
    Expert Rev Mol Med; 2006 Jan; 8(2):1-22. PubMed ID: 16515728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the understanding of polycystic kidney disease.
    Bacallao RL; Carone FA
    Curr Opin Nephrol Hypertens; 1997 Jul; 6(4):377-83. PubMed ID: 9263688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystin-1 expression in fetal, adult and autosomal dominant polycystic kidney.
    Chae SW; Cho EY; Park MS; Lee KB; Kim H; Kim U
    J Korean Med Sci; 2006 Jun; 21(3):425-9. PubMed ID: 16778383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal disease. II. The polycystic kidney disease 1 (PKD-1) gene: an important clue in the study of renal cyst formation.
    Ong AC
    J R Coll Physicians Lond; 1997; 31(2):141-6. PubMed ID: 9131510
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress in the understanding of polycystic kidney disease.
    Torres VE; Harris PC
    Nat Rev Nephrol; 2019 Feb; 15(2):70-72. PubMed ID: 30607031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell Proliferation and Apoptosis in ADPKD.
    Lee EJ
    Adv Exp Med Biol; 2016; 933():25-34. PubMed ID: 27730432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation.
    Huang J; Zhou S; Niu X; Hu B; Li Q; Zhang F; Zhang X; Cai X; Lou Y; Liu F; Xu C; Wang Y
    Stem Cell Res Ther; 2017 Sep; 8(1):196. PubMed ID: 28927462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal Dominant Polycystic Kidney Disease: A Path Forward.
    Rangan GK; Lopez-Vargas P; Nankivell BJ; Tchan M; Tong A; Tunnicliffe DJ; Savige J
    Semin Nephrol; 2015 Nov; 35(6):524-37. PubMed ID: 26718155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.